Deferred Tax Assets, Valuation Allowance of Applied Therapeutics, Inc. from 31 Dec 2018 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Applied Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2018 to 31 Dec 2024.
  • Applied Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $180,769,000, a 20% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Applied Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $180,769,000 +$29,547,000 +20% 31 Dec 2024 10-K 15 Apr 2025 2024 FY
Q4 2023 $151,222,000 +$17,045,000 +13% 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q4 2022 $134,177,000 +$31,245,000 +30% 31 Dec 2022 10-K 06 Mar 2024 2023 FY
Q4 2021 $102,932,000 +$39,686,000 +63% 31 Dec 2021 10-K 23 Mar 2023 2022 FY
Q4 2020 $63,246,000 +$41,704,000 +194% 31 Dec 2020 10-K 10 Mar 2022 2021 FY
Q4 2019 $21,542,000 +$15,233,000 +241% 31 Dec 2019 10-K 18 Mar 2021 2020 FY
Q4 2018 $6,309,000 31 Dec 2018 10-K 13 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.